Zamboni BA - Search Results

1

A review of study designs and outcomes of phase I clinical studies of nanoparticle agents compared with small-molecule anticancer agents.

Caron WP, Morgan KP, Zamboni BA, Zamboni WC. Caron WP, et al. Among authors: zamboni ba. Clin Cancer Res. 2013 Jun 15;19(12):3309-15. doi: 10.1158/1078-0432.CCR-12-3649. Epub 2013 Apr 25. Clin Cancer Res. 2013. PMID: 23620407

2

Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.

Zamboni WC, Ramalingam S, Friedland DM, Edwards RP, Stoller RG, Strychor S, Maruca L, Zamboni BA, Belani CP, Ramanathan RK. Zamboni WC, et al. Among authors: zamboni ba. Clin Cancer Res. 2009 Feb 15;15(4):1466-72. doi: 10.1158/1078-0432.CCR-08-1405. Epub 2009 Feb 3. Clin Cancer Res. 2009. PMID: 19190127 Free PMC article. Clinical Trial.

3

Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents.

Schell RF, Sidone BJ, Caron WP, Walsh MD, White TF, Zamboni BA, Ramanathan RK, Zamboni WC. Schell RF, et al. Among authors: zamboni ba. Nanomedicine. 2014 Jan;10(1):109-17. doi: 10.1016/j.nano.2013.07.005. Epub 2013 Jul 24. Nanomedicine. 2014. PMID: 23891988 Free PMC article.

4

Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors.

Combest AJ, Roberts PJ, Dillon PM, Sandison K, Hanna SK, Ross C, Habibi S, Zamboni B, Müller M, Brunner M, Sharpless NE, Zamboni WC. Combest AJ, et al. Oncologist. 2012;17(10):1303-16. doi: 10.1634/theoncologist.2012-0274. Epub 2012 Sep 19. Oncologist. 2012. PMID: 22993143 Free PMC article.

5

Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors.

Fakih MG, Creaven PJ, Ramnath N, Trump D, Javle M, Strychor S, Repinski TV, Zamboni BA, Schwarz JK, French RA, Zamboni WC. Fakih MG, et al. Among authors: zamboni wc, zamboni ba. Clin Cancer Res. 2005 Aug 15;11(16):5942-9. doi: 10.1158/1078-0432.CCR-05-0116. Clin Cancer Res. 2005. PMID: 16115937 Clinical Trial.

6

Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.

Zamboni WC, Strychor S, Joseph E, Walsh DR, Zamboni BA, Parise RA, Tonda ME, Yu NY, Engbers C, Eiseman JL. Zamboni WC, et al. Among authors: zamboni ba. Clin Cancer Res. 2007 Dec 1;13(23):7217-23. doi: 10.1158/1078-0432.CCR-07-1035. Clin Cancer Res. 2007. PMID: 18056203

7

Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors.

Zamboni WC, Maruca LJ, Strychor S, Zamboni BA, Ramalingam S, Edwards RP, Kim J, Bang Y, Lee H, Friedland DM, Stoller RG, Belani CP, Ramanathan RK. Zamboni WC, et al. Among authors: zamboni ba. J Liposome Res. 2011 Jun;21(2):158-65. doi: 10.3109/08982104.2010.496085. Epub 2010 Jul 14. J Liposome Res. 2011. PMID: 20626314 Clinical Trial.

8

Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.

Wu H, Ramanathan RK, Zamboni BA, Strychor S, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Maruca LJ, Bang YJ, Zamboni WC. Wu H, et al. Among authors: zamboni ba. J Clin Pharmacol. 2012 Feb;52(2):180-94. doi: 10.1177/0091270010394851. J Clin Pharmacol. 2012. PMID: 21233302 Clinical Trial.

9

Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer.

Zamboni WC, Combest AJ, DeLoia JA, Edwards RP, Bridges AS, Zamboni BA, Walko CM, Yu AY, Krivak TC, Kelley JL. Zamboni WC, et al. Among authors: zamboni ba. Cancer Chemother Pharmacol. 2011 Nov;68(5):1255-62. doi: 10.1007/s00280-011-1609-9. Epub 2011 Mar 25. Cancer Chemother Pharmacol. 2011. PMID: 21437702

10

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients.

La-Beck NM, Zamboni BA, Gabizon A, Schmeeda H, Amantea M, Gehrig PA, Zamboni WC. La-Beck NM, et al. Among authors: zamboni ba. Cancer Chemother Pharmacol. 2012 Jan;69(1):43-50. doi: 10.1007/s00280-011-1664-2. Epub 2011 May 18. Cancer Chemother Pharmacol. 2012. PMID: 21590446 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters